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Abstract: Subjective global assessment (SGA) is associated with
mortality in end-stage renal disease (ESRD) patients. However, little
is known whether improvement or deterioration of nutritional status
after dialysis initiation influences the clinical outcome. We aimed to
elucidate the association between changes in nutritional status deter-
mined by SGA during the first year of dialysis and all-cause mortality in
incident ESRD patients.
This was a multicenter, prospective cohort study. Incident dialysis
patients with available SGA data at both baseline and 12 months after
dialysis commencement (n¼ 914) were analyzed. Nutritional status was
defined as well nourished (WN, SGA A) or malnourished (MN, SGA B
or C). The patients were divided into 4 groups according to the change in
nutritional status between baseline and 12 months after dialysis com-
mencement: group 1, WN to WN; group 2, MN to WN; group 3, WN to
MN; and group 4, MN to MN. Cox proportional hazard analysis was
performed to clarify the association between changes in nutritional
status and mortality.
Being in theMNgroup at 12months after dialysis initiation, but not at
baseline, was a significant risk factor formortality. Therewas a significant
difference in the 3-year survival rates among the groups (group 1, 92.2%;MD, PhD, Nam-H hD,
ang, MD, PhD
ratio [HR] 2.77, 95% confidence interval [CI] 1.27–6.03, P¼ 0.01)
whereas the mortality risk was significantly lower in group 2 compared
with group 4 (HR 0.35, 95% CI 0.17–0.71, P< 0.01) even after adjust-
ment for confounding factors. Moreover, mortality risk of group 3 was
significantly higher than in group 2 (HR 2.89, 95% CI 1.22–6.81,
P¼ 0.02); there was no significant difference between groups 1 and 2.
The changes in nutritional status assessed by SGA during the first
year of dialysis were associated with all-cause mortality in incident
ESRD patients.
(Medicine 95(7):e2714)
Abbreviations: BMI = body mass index, CRC = Clinical Research
Center, ESRD = end-stage renal disease, HD = hemodialysis, hs-
CRP = high-sensitivity C-reactive protein, MN = malnourished, PD
= peritoneal dialysis, PEW = protein–energy wasting, SGA =
subjective global assessment, WN = well nourished.
INTRODUCTION
P rotein–energy wasting (PEW) is a syndrome of protein andenergy wasting, malnutrition, and inflammation.1,2 In
patients with end-stage renal disease (ESRD), PEW is preva-
lent, ranging from 16% to 62% depending on the study subjects
and assessment methods,3–5 and is attributed to not only
insufficient nutrient intake but also oxidative stress, metabolic
acidosis, and nutrient loss during dialysis.3,6 In addition, mount-
ing evidence has shown that PEW is a significant risk factor for
morbidity and mortality in these patients.7,8 Therefore, con-
tinuous monitoring of nutritional status and early detection and
treatment of PEWmay be important for the clinical outcomes in
ESRD patients.
To detect PEW in patients with ESRD, various clinical and
biochemical parameters have been used in clinical practice,
including body mass index (BMI), muscle mass, dietary protein
or energy intake, and serum albumin or prealbumin concen-
trations.6,9,10 However, no single parameter can definitively
ascertain PEW; therefore, the International Society of Renal
Nutrition and Metabolism panel has proposed diagnostic criteria
for PEW in patients undergoing dialysis consisting of 4 categories
(serum chemistry, body mass, muscle mass, and dietary intake).6
At least 3 compatible findings among the 4 categories are required
to diagnose PEW. However, these parameters are influenced by
acute inflammation accompanied by infectious/inflammatory
conditions and a patient’s hydration status. To overcome theseassessment (SGA) has been suggested as
od for evaluating nutritional status in
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scale consisting of 2 categories: medical history and physical
examination. The medical history section includes weight
change, dietary intake, gastrointestinal symptoms, functional
Incident ESRD patients 
(n=2,058) 
From Nov 2008 to Feb 2014 
Enrolled patients 
(n=914) 
• Exclusion (n=1,144)  
1. Censored within 1 year (n=539)* 
- d/t death (n=122) 
- d/t drop out (n=417) 
- Loss of follow-up (n=98) 
- Withdrawal of consent (n=63) 
- Transferred to other hospital (n=191) 
- Kidney transplantaon (n=65) 
* Unavailable baseline SGA data (n=71) 
 
2. Unavailable SGA data (n=605) 
- No baseline & 12 months SGA data (n=123) 
- No baseline SGA data (n=32) 
- No 12 months SGA data (n=450) 
TABLE 1. Nutritional Status Groups Based on Subjective Glo-
bal Assessment at Baseline and 12 Months After Dialysis
Commencement
Baseline,
n (%)
12 mos,
n (%)
WN subgroup (SGA A) 1157 (63.2) 833 (88.1)
MN subgroup (SGA B or C) 675 (36.8) 113 (11.9)
SGA B 663 (36.2) 112 (11.8)
SGA C 12 (0.7) 1 (0.1)
Total 1832 946
Unmeasured SGA 226 573
Censored within 1 year – 539
Total (including the cases
without SGA score)
2058 2058
Medicine  Volume 95, Number 7, February 2016Subjective global assessment is a well-established tool to
assess nutritional status and a feasible method to ascertain PEW
based on a patient’s medical history and physical examin-
ation.11,12 Moreover, it can be applied quickly in clinics without
technical difficulties. Although a number of previous studies
found a significant association between SGA score and
mortality in patients with ESRD, the SGA score was determined
only once in most of those studies.8,13 Especially in incident
ESRD patients, the SGA score only at the time of dialysis
initiation was usually used to define nutritional status.9,14
Because patient’s nutritional status can change as a result of
improved oral intake, correction of acidosis, and nutrient loss
through the dialysate after commencing ESRD treatment, the
change in nutritional status may affect patient survival in
incident dialysis patients. To date, however, this issue has
not been explored. Therefore, in the present study, a compre-
hensive mortality analysis was performed according to the
changes in SGA score during the first year of dialysis in incident
dialysis patients from the Clinical Research Center for ESRD
(CRC for ESRD) cohort, a nationwide prospective observa-
tional multicenter cohort.
METHODS
Ethics
The current study was conducted in accordance with the
Declaration of Helsinki. The study protocol was approved by
the institutional review board at each participating center, and
all patients provided written informed consent to participate in
this study.
Subjects
All consecutive ESRD patients who started hemodialysis
(HD) or peritoneal dialysis (PD) between November 1, 2008
and February 28, 2014 at 36 centers of the CRC for ESRD in
Korea were initially recruited for this prospective observational
multicenter study. We excluded patients who were younger than
18 years, had a history of kidney transplantation before dialysis
therapy, or had an underlying active malignancy. Consequently,
2058 patients were initially eligible to be enrolled at the time of
dialysis initiation. Because the current study aimed at clarifying
the impact of the change in nutritional status assessed by SGA
during the first year of dialysis, we first analyzed the data from
the entire cohort (n¼ 2058), and then focused on the patients
whose both baseline and 12-month SGA data were available
(n¼ 914) (Figure 1). The numbers of the patients in SGA groups
at baseline and at 12 months are described in Table 1.
Data Collection
Demographic and clinical data were recorded at the time of
study entry, including age, sex, BMI calculated as weight/
height2 (kg/m2), blood pressure, dialysis modality, and comor-
bidities, such as diabetes mellitus, coronary artery disease,
cerebrovascular disease, peripheral artery disease, heart failure,
and moderate or severe liver disease. Coronary artery disease
was defined as a history of angina, myocardial infarction,
angioplasty or coronary artery bypass graft, and cerebrovascular
accident as a history of transient ischemic attack, stroke, or
carotid endarterectomy. A history of claudication, foot ulcera-
tion, and/or ischemic limb loss, and any peripheral revasculari-
Kwon et alzation procedure was considered peripheral artery disease. The
following baseline laboratory data were measured from fasting
blood samples, which were drawn before the start of HD on the
2 | www.md-journal.comday of a midweek session in HD patients and at 2 hours after the
first PD exchange with 1.5% dextrose dialysate in PD patients,
close to the time of discharge, and every 3 months thereafter.
The following laboratory data were measured: white blood cell
counts and hemoglobin, blood urea nitrogen, creatinine,
calcium, phosphorus, intact parathyroid hormone, glucose, uric
acid, albumin, and total cholesterol concentrations. High-sen-
sitivity C-reactive protein (hs-CRP) concentrations were
measured by latex-enhanced immunonephelometry using a
BNII analyzer (Dade Behring; Newark, DE).
Subjective Global Assessment
Nutritional status was determined using the 7-point SGA
FIGURE 1. Flow diagram of the study subjects.MN¼malnourished, SGA¼ subjective global assessment, WN¼
well nourished.
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capacity, and disease and comorbidity data. The physical exam-
ination section includes loss of subcutaneous fat, muscle wast-
ing, and edema. The trained investigators rated each item from 1
to 7, and decided the overall SGA score. Based on the overall
SGA score, the patients were categorized into 3 groups as SGA
A (SGA score 6–7, well nourished, [WN]), B (SGA score 3–5,
mildly to moderately malnourished [MN]), or C (SGA score 1–
2, severely MN). However, since the number of SGA C patients
was too small to be analyzed separately, MN patients were
combined into the same group (MN group, SGA B or C).
Finally, patients were classified into 4 groups according to
the 1-year changes in nutritional status: group 1, WN to
WN; group 2, MN to WN; group 3, WN to MN; and group
4, MN to MN.
Outcome Measures
All deaths were retrieved from the database of the CRC for
ESRD and carefully reviewed. The primary endpoint was all-
cause mortality, and the survival duration data were calculated
from the time of dialysis initiation to death, dropout, or Feb-
ruary 28, 2015.
Statistical Analyses
Statistical analyses were performed using SPSS for Win-
dows version 21 (IBM Corporation; Armonk, NY). Data are
expressed as mean standard deviation or median (interquar-
tile range) for continuous variables and number (percentage)
for categorical variables. The normality of distribution was
assessed using the Shapiro–Wilk test. The differences between
the groups were analyzed using analysis of variance or Krus-
kal–Wallis test for continuous variables and the x2 test for
categorical variables, and paired t test or Wilcoxon signed rank
test was used to compare baseline and 12-month values.
Cumulative survival graphs for all-cause mortality were gener-
ated using the Kaplan–Meier analyses, and log-rank test was
used to compare the survival rates between the groups. The
prognostic value of the changes in nutritional status for
mortality was verified using Cox proportional hazards
regression analysis. A P value less than 0.05 was considered
statistically significant.
RESULTS
Data From the Entire Cohort
Of 2058 incident dialysis patients, nutritional status group
assessed by SGA was determined in 1832 patients at baseline
and in 946 patients at 12 months after dialysis commencement.
The mean age of the entire cohort was 60.4 14.3 years, and
62.1% were men. A total of 1473 patients (71.6%) started HD,
and 1114 (54.1%) had diabetes. The distribution of nutritional
status group at baseline was as follows: WN group, 1157
(63.2%) and MN group, 675 (36.8%) (Table 1).
During a median follow-up of 31 months, 323 patients
(15.7% of the entire cohort) died, and of the patients with SGA
data at baseline, 281 patients (15.3%) died. A Kaplan–Meier
plot demonstrated that 3-year survival rates were significantly
higher in the WN group than in the MN group at baseline (WN
group, 85.7%; MN group, 75.1%, P< 0.001) (Supplementary
Figure 1, http://links.lww.com/MD/A698). The impact of the
baseline nutritional status assessed by SGA on all-cause
Medicine  Volume 95, Number 7, February 2016mortality was statistically significant in univariate Cox pro-
portional regression analysis, but not in multivariate analysis
(Supplementary Table 1, http://links.lww.com/MD/A698). In
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.contrast, the 12-month nutritional status was significantly
associated with all-cause mortality in both univariate and multi-
variate Cox regression models.
Characteristics of the Patients With Available
Subjective Global Assessment Data at Baseline
and 12 Months After Dialysis Initiation
To clarify the impact of nutritional status changes in the
first year after dialysis initiation, we analyzed the patients
with available baseline and 12-month SGA data (n¼ 914).
The baseline demographics, clinical characteristics, and
laboratory findings are shown in Table 2. At the time of
dialysis commencement, 651 patients (71.2%) belonged to the
WN subgroup and 263 patients (28.8%) to the MN subgroup.
We categorized the patients into 4 groups according to nutri-
tional status changes from baseline to after 12 months (group
1, WN to WN; group 2, MN to WN; group 3, WN to MN; and
group 4, MN to MN). After 12 months, the number of patients
whose nutritional status was changed from WN to MN was 48
out of 651 patients (7.4%), and the nutritional status of 213 out
of 263 patients (81.0%) was changed from MN to WN.
Therefore, the numbers of patients in each group were 603,
213, 48, and 50, respectively. There were significant differ-
ences in age, the proportion of diabetic patients, and serum
albumin, creatinine, and hs-CRP concentrations among the 4
groups (P< 0.05 to P< 0.001). However, BMI, systolic and
diastolic blood pressure, and serum total cholesterol concen-
trations were comparable.
Effects of Baseline and 12-Month Nutritional
Status Assessed by Subjective Global Assessment
on All-Cause Mortality
During a median follow-up of 30 months, 108 patients
(11.8%) died. Univariate Cox regression analysis revealed that
being in the MN subgroup at baseline was significantly associ-
ated with all-cause mortality (hazard ratio [HR] 1.81, 95%
confidence interval [CI] 1.23–2.67, P< 0.01) (Table 3). In
multivariate Cox regression analysis, however, the significance
of being in the MN subgroup at baseline as a predictor of all-
cause mortality disappeared after adjusting for confounding
factors (HR 1.13, 95% CI 0.71–1.79, P¼ 0.62). In contrast,
being in the MN subgroup at 12 months was a significant risk
factor for all-cause mortality in both univariate and multivariate
Cox regression analyses (in univariate analysis: HR 3.69, 95%
CI 2.39–5.68, P< 0.001; in multivariate analysis: HR 2.82,
95% CI 1.65–4.80, P< 0.001).
Changes in Body Mass Index and Nutritional
Biochemical Markers in the 4 Groups
Compared with baseline, serum albumin concentrations
were significantly increased after 12 months in all 4 groups
(P¼ 0.01 to P< 0.001) (Table 4 and Figure 2). After 12 months,
BMI was also significantly increased in group 2 (P¼ 0.01).
However, there were no significant differences in the changes in
BMI and serum albumin concentrations among the 4 groups. In
contrast, serum creatinine concentrations were significantly
increased in group 3 (P< 0.01) and group 4 (P< 0.001) after
12 months, whereas they were slightly decreased in group 2, and
these changes were significantly different among the 4 groups
Nutritional Status Change and Mortality(P< 0.01). Meanwhile, there were no significant changes in
serum cholesterol concentrations during the first year of dialysis
treatment in the 4 groups.
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TABLE 2. Demographics, Clinical Characteristics, and Laboratory Findings in the 4 Groups
Total
(n¼ 914)
Nutritional Status Group Change
Group 1
(WN to WN)
(n¼ 603)
Group 2
(MN to WN)
(n¼ 213)
Group 3
(WN to MN)
(n¼ 48)
Group 4
(MN to MN)
(n¼ 50) P
Age, y 54.6 14.0 53.5 13.8 57.2 14.0 51.5 14.5 58.2 14.5 <0.01
Male, % 547 (59.8) 374 (62.0) 118 (55.4) 24 (50.0) 31 (62.0) 0.17
Dialysis modality 0.27
Hemodialysis, % 554 (60.6) 368 (61.0) 135 (63.4) 24 (50.0) 27 (54.0)
Peritoneal dialysis, % 360 (39.4) 235 (39.0) 78 (36.6) 24 (50.0) 23 (46.0)
Body mass index, kg/m2 22.7 3.3 22.8 3.3 22.4 3.4 22.8 2.9 22.6 3.8 0.42
Systolic blood pressure, mm Hg 140.3 23.1 140.2 22.9 138.9 23.4 147.1 25.3 140.4 20.5 0.21
Diastolic blood pressure, mm Hg 77.7 14.3 77.6 14.3 76.8 14.2 80.9 16.7 79.8 12.1 0.27
Underlying diseases
Diabetes mellitus, % 490 (53.6) 301 (49.9) 126 (59.2) 27 (56.3) 36 (72.0) <0.01
Coronary artery disease, % 114 (12.5) 64 (10.6) 32 (15.0) 6 (12.5) 12 (24.0) 0.03
Peripheral artery disease, % 73 (8.0) 40 (6.6) 17 (8.0) 6 (12.5) 10 (20.0) 0.01
Heart failure, % 106 (11.6) 63 (10.4) 25 (11.7) 6 (12.5) 12 (24.0) 0.04
Cerebrovascular accident, % 81 (8.9) 43 (7.1) 22 (10.3) 6 (12.5) 10 (20.0) 0.01
Chronic lung disease, % 69 (7.5) 38 (6.3) 18 (8.5) 6 (12.5) 7 (14.0) 0.09
Liver disease, moderate to severe, % 34 (3.7) 20 (3.3) 11 (5.2) 2 (4.2) 1 (2.0) 0.58
Laboratory
Hemoglobin, g/dL 8.9 1.7 8.9 1.7 8.9 1.7 9.0 1.3 9.0 1.5 0.96
Albumin, g/dL 3.4 0.6 3.4 0.6 3.3 0.6 3.4 0.6 3.1 0.7 <0.01
Blood urea nitrogen, mg/dL 83.5 39.0 84.1 38.1 84.8 42.8 77.8 31.7 77.3 39.0 0.45
Creatinine, mg/dL 8.8 4.3 9.0 4.1 8.9 5.1 7.6 2.5 6.7 3.2 <0.001
Glucose, mg/dL 139.8 73.4 138.0 67.2 143.1 88.7 139.4 77.1 148.5 70.4 0.70
Total cholesterol, mg/dL 160.0 48.2 162.0 47.9 158.5 48.8 155.5 42.8 146.5 52.7 0.17
Triglyceride, mg/dL 127.1 74.4 127.0 75.3 131.8 76.2 109.4 45.6 124.3 77.0 0.40
LDL cholesterol, mg/dL 91.4 37.6 93.1 36.9 90.3 39.0 87.1 32.7 80.1 44.0 0.18
hs-CRP, mg/dL 0.30
(0.06–1.40)
0.26
(0.05–1.29)
0.40
(0.09–2.07)
0.13
(0.06–0.85)
0.56
(0.13–1.66)
0.03
All data are expressed as number (percentage) for categorical variables, mean standard deviations for continuous variables with a normal
with
pro
Kwon et al Medicine  Volume 95, Number 7, February 2016Comparison of All-Cause Mortality According to
Changes in Nutritional Status
To investigate differences in all-cause mortality accord-
ing to changes in nutritional status assessed by SGA, the
patient survival rates of the 4 groups were compared.
Kaplan–Meier survival curve analysis demonstrated that
the 3-year survival rates in each group were 92.2%, 86.0%,
78.2%, and 63.5%, respectively, and there was a significant
difference in patient survival across the 4 groups (log-rank
test, P< 0.001) (Figure 3). However, pairwise comparison
among the groups revealed that the difference between groups
1 and 2 did not reach statistical significance (P¼ 0.06).
Multivariate Cox regression analysis also revealed that the
risk for mortality was significantly higher in group 3 than
group 1 (HR 2.77, 95% CI 1.27–6.03, P¼ 0.01), whereas the
mortality risk was significantly lower in group 2 compared
with group 4 (HR 0.35, 95% CI 0.17–0.71, P< 0.01) even
after adjustment for confounding factors. Moreover, mortality
risk of group 3 was significantly higher than in group 2 (HR
distribution, or medians (interquartile ranges) for continuous variables
hs-CRP¼ high-sensitivity C-reactive protein, LDL¼ low-density lipo2.89, 95% CI 1.22–6.81, P¼ 0.02), whereas there was no
significant difference in the risk for mortality between groups
1 and 2 (Table 5).
4 | www.md-journal.comNext, we verified the predictive power of nutritional status
change for mortality by performing 2 additional analyses.
Firstly, we subdivided the patients according to their baseline
SGA, and performed multivariate Cox regression analyses
separately. In theWN subgroup at baseline (n¼ 651), deteriora-
tion of nutritional status (WN to MN) was significantly associ-
ated with a higher all-cause mortality (HR 2.48, 95% CI 1.10–
5.59, P¼ 0.03), whereas improvement of nutritional status (MN
to WN) was associated with a significantly lower mortality in
the MN subgroup at baseline (n¼ 263) (HR 0.26, 95% CI 0.11–
0.57, P< 0.01), even after adjustment for age, sex, dialysis
modality, BMI, diabetes mellitus, coronary artery disease,
cerebrovascular disease, and serum albumin, creatinine, total
cholesterol, and hs-CRP concentrations (Supplementary Table
2, http://links.lww.com/MD/A698). Secondly, both baseline
SGA and delta SGA (differences in SGA score in 7-point scale
between baseline and 12 months) were incorporated in multi-
variate Cox regression analysis, and it was found that an
increase in SGA score by 1 point after 12 months of dialysis
a skewed distribution.
tein, MN¼malnourished, WN¼well nourished.was independently associated with a 34% decrease in all-cause
mortality risk (Supplementary Table 3, http://links.lww.com/
MD/A698).
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 3. Effects of Nutritional Status Group at Baseline and After 12 Months on All-Cause Mortality

Baseline
P
12 mos
PVariables HR (95% CI) HR (95% CI)
Univariate analysis
Nutritional status group
WN subgroup Reference – Reference –
MN subgroup 1.81 (1.23–2.67) <0.01 3.69 (2.39–5.68) <0.001
Multivariate analysis
Nutritional status group
WN subgroup Reference – Reference –
MN subgroup 1.13 (0.71–1.79) 0.62 2.82 (1.65–4.80) <0.001
Age (per 1-year increase) 1.04 (1.02–1.06) <0.001 1.04 (1.02–1.06) <0.001
Male (versus female) 1.67 (1.03–2.70) 0.04 1.75 (1.08–2.84) 0.02
Peritoneal dialysis (versus hemodialysis) 0.84 (0.52–1.34) 0.46 0.84 (0.52–1.36) 0.48
Body mass index (per 1-kg/m2 increase) 0.96 (0.89–1.03) 0.24 0.95 (0.89–1.02) 0.17
Diabetes mellitus 1.48 (0.91–2.41) 0.12 1.39 (0.86–2.26) 0.18
Coronary artery disease 1.01 (0.61–1.69) 0.96 0.97 (0.58–1.60) 0.89
Cerebrovascular accident 1.32 (0.60–2.91) 0.50 0.97 (0.43–2.22) 0.95
Albumin (per 1-g/dL increase) 0.70 (0.48–1.00) 0.05 0.69 (0.48–0.98) 0.04
Creatinine (per 1-mg/dL increase) 0.88 (0.81–0.95) <0.01 0.89 (0.82–0.96) <0.01
Total cholesterol (per 1-mg/dL increase) 1.00 (0.99–1.00) 0.35 1.00 (1.00–1.00) 0.77
hs-CRP (per 1-mg/dL increase) 1.01 (0.94–1.09) 0.80 1.00 (0.93–1.07) 0.96
CI¼ confidence interval, HR¼ hazard ratio, hs-CRP¼ high-sensitivity C-reactive protein, MN¼malnourished, WN¼well nourished.
The number of the patients in this analysis was 914.
TABLE 4. Comparisons of the Changes in Body Mass Index and Nutritional Biochemical Markers Among the 4 Groups
Total
(n¼ 914)
Nutritional Status Group Change
Group 1
(WN to WN)
(n¼ 603)
Group 2
(MN to WN)
(n¼ 213)
Group 3
(WN to MN)
(n¼ 48)
Group 4
(MN to MN)
(n¼ 50) P
Albumin, baseline, g/dL 3.4 0.6 3.4 0.6 3.3 0.6 3.4 0.6 3.1 0.7 <0.01
Albumin, 12 mos, g/dL 3.8 0.6 3.8 0.5y 3.8 0.6y 3.7 0.5§ 3.5 0.8z 0.18
Delta albumin, g/dL 0.38 0.76 0.35 0.69 0.47 0.90 0.29 0.70 0.40 0.94 0.29
Body mass index, baseline, kg/m2 22.7 3.3 22.8 3.3 22.4 3.4 22.8 2.9 22.6 3.8 0.42
Body mass index, 12 mos, kg/m2 22.9 3.3 23.0 3.3 22.6 3.3§ 22.7 3.1 23.1 4.3 0.60
Delta body mass index, kg/m2 0.17 1.81 0.13 1.68 0.32 1.81 0.20 2.00 0.39 2.76 0.24
Creatinine, baseline, mg/dL 8.8 4.3 9.0 4.1 8.9 5.1 7.6 2.5 6.7 3.2 <0.001
Creatinine, 12 mos, mg/dL 9.1 3.5 9.2 3.4 8.7 3.7 9.3 3.3z 9.1 4.6y 0.42
Delta creatinine, mg/dL 0.42 4.50 0.29 4.44 0.05 4.67 1.62 3.86 2.49 4.26 <0.01
Total cholesterol, baseline, mg/dL 160.0 48.2 162.0 47.9 158.5 48.8 155.5 42.8 146.5 52.7 0.17
Total cholesterol, 12 mos, mg/dL 160.5 40.6 160.1 39.2 162.1 41.4 157.1 43.3 160.4 49.3 0.89
Delta total cholesterol, mg/dL 1.49 56.45 0.96 55.82 6.86 55.98 1.89 53.12 9.58 66.64 0.33
hs-CRP, baseline, mg/dL 0.30 (0.06–1.40) 0.26 (0.05–1.29) 0.40 (0.09–2.07) 0.13 (0.06–0.85) 0.56 (0.13–1.66) 0.03
hs-CRP, 12 mos, mg/dL 0.11 (0.03–0.41) 0.10 (0.03–0.37)y 0.14 (0.04–0.43)y 0.11 (0.04–0.51) 0.23 (0.04–0.89)y 0.13
Delta hs-CRP, mg/dL 0.06 (0.90–0.04) 0.07 (0.82–0.03) 0.09 (1.72–0.04) 0.00 (0.48–0.34) 0.07 (1.33–0.31) 0.23
hs-CRP,¼ high-sensitivity C-reactive protein, MN¼malnourished, WN¼well nourished.
Values are expressed as mean standard deviations for continuous variables with a normal distribution, or medians (interquartile ranges) for
continuous variables with a skewed distribution, and P values obtained from comparison between baseline and 12 months by paired t test or Wilcoxon
signed-rank test were described as follows:
yP< 0.001.
zP< 0.01.
§P¼ 0.01.
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Kwon et al Medicine  Volume 95, Number 7, February 2016Lastly, when the patients were restratified according to the
trend of nutritional status change during the first year of dialysis
as stationary (WN toWN,MN toMN), improving (MN toWN),
and worsening (WN to MN), the risk for all-cause mortality of
the worsening nutritional status group was significantly higher
compared with the other 2 groups (stationary and improving
groups) (P< 0.05) (Figure 4). Additionally, the patients’ group
with worsening nutritional status assessed by 7-point scale SGA
also showed poorer survival than stationary or improving
groups, although statistical difference was not significant in
Kaplan–Meier plot (Supplementary Figure 2, http://links.lww.-
com/MD/A698).
DISCUSSION
Clinically, SGA is a simple method to assess nutritional
FIGURE 2. Changes in serum albumin levels, body mass index, and
12 months.status in various patients, including ESRD patients. Previous
studies found that SGA score was an independent predictor of
mortality in patients undergoing dialysis.8,9,13,14 As most of
FIGURE 3. Kaplan–Meier plot for all-cause mortality of the groups
according to the nutritional status change assessed by subjective
global assessment (3 categories). Numbers in the box are P values
of pairwise comparisons between 2 groups. WN group: SGA A
group, MN group: SGA B or C group. MN¼malnourished,
SGA¼ subjective global assessment, WN¼well nourished.
6 | www.md-journal.comthose studies used SGA scores measured just once in their
analysis, it is unclear whether changes in SGA scores exerted
any effect on clinical outcomes in dialysis patients. In this study,
we showed that the changes in nutritional status assessed by
SGA during the first year of dialysis were associated with
mortality in incident ESRD patients.
It is well-known that PEW is a myriad factor associated
with poor clinical outcomes in various patient populations.15–17
Therefore, a number of interventions have been tried to prevent
PEW to improve patient morbidity and mortality; however, it is
still prevalent in some patient groups, especially in ESRD
patients. In the first study in which SGA was used in ESRD
patients, 18 of 59 prevalent dialysis patients (30.5%; 9 of 23 PD
patients and 9 of 36 HD patients) were classified as MN.18 The
7-point SGA used in the current study was then validated in the
Canada-USA study, in which 51.2% of 680 incident PD patients
were revealed to be mildly to moderately MN.19 The Nether-
lands Co-operative Study on the Adequacy of Dialysis-2
(NECOSAD-II) study also used the SGA to determine nutri-
tional status and found that 22.9% and 5.1% of ESRD patients
had moderate and severe PEW, respectively, at 3 months.14 This
wide range of the proportion of patients with malnutrition in
previous studies may be attributed to the differences in the study
population (HD versus PD), the time (prevalent versus incident)
and methods of assessment, and predialysis management. This
study showed that the prevalence of mild to moderate malnu-
trition in incident dialysis patients was 28.8% at baseline, which
was consistent with the NECOSAD-II study; however, it
decreased to 10.7% after 12 months of dialysis. We surmised
that the decrease in the proportion of MN ESRD patients 12
months after dialysis initiation was due to improved dietary
intake and reduced gastrointestinal symptoms, leading to weight
gain and functional capacity improvement, after the correction
um creatinine and total cholesterol concentrations from baseline toof uremia and acidosis.
Numerous previous studies have demonstrated that PEW
determined by the SGA is a significant independent predictor of
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 5. Impact of the Changes in Nutritional Status Group on All-Cause Mortality
Variables HR (95% CI) P HR (95% CI) P HR (95% CI) P
Univariate analysis
Nutritional status group change
Group 1 (WN to WN) Reference – 0.65 (0.41–1.03) 0.07 0.17 (0.10–0.30) <0.001
Group 2 (MN to WN) 1.55 (0.97–2.46) 0.07 Reference – 0.26 (0.14–0.50) <0.001
Group 3 (WN to MN) 3.16 (1.72–5.80) <0.001 2.04 (1.05–3.96) 0.04 0.54 (0.26–1.14) 0.10
Group 4 (MN to MN) 5.87 (3.29–10.46) <0.001 3.79 (2.01–7.15) <0.001 Reference –
Multivariate analysis
Nutritional status group change
Group 1 (WN to WN) Reference – 1.04 (0.61–1.79) 0.88 0.36 (0.18–0.72) <0.01
Group 2 (MN to WN) 0.96 (0.56–1.64) 0.88 Reference – 0.35 (0.17–0.71) <0.01
Group 3 (WN to MN) 2.77 (1.27–6.03) 0.01 2.89 (1.22–6.81) 0.02 1.00 (0.39–2.52) 0.99
Group 4 (MN to MN) 2.78 (1.40–5.53) <0.01 2.90 (1.40–5.99) <0.01 Reference –
Age (per 1-year increase) 1.04 (1.02–1.06) <0.001 1.04 (1.02–1.06) <0.001 1.04 (1.02–1.06) <0.001
Male (versus female) 1.75 (1.07–2.85) 0.03 1.75 (1.07–2.85) 0.03 1.75 (1.07–2.85) 0.03
Peritoneal dialysis (versus hemodialysis) 0.84 (0.52–1.35) 0.48 0.84 (0.52–1.35) 0.48 0.84 (0.52–1.35) 0.48
Body mass index (per 1-kg/m2 increase) 0.95 (0.89–1.02) 0.17 0.95 (0.89–1.02) 0.17 0.95 (0.89–1.02) 0.17
Diabetes mellitus 1.39 (0.86–2.27) 0.18 1.39 (0.86–2.27) 0.18 1.39 (0.86–2.27) 0.18
Coronary artery disease 0.97 (0.58–1.61) 0.90 0.97 (0.58–1.61) 0.90 0.97 (0.58–1.61) 0.90
Cerebrovascular accident 0.97 (0.42–2.21) 0.94 0.97 (0.42–2.21) 0.94 0.97 (0.42–2.21) 0.94
Albumin (per 1-g/dL increase) 0.69 (0.48–0.98) 0.04 0.69 (0.48–0.98) 0.04 0.69 (0.48–0.98) 0.04
Creatinine (per 1-mg/dL increase) 0.89 (0.82–0.96) <0.01 0.89 (0.82–0.96) <0.01 0.89 (0.82–0.96) <0.01
Total cholesterol (per 1-mg/dL increase) 1.00 (1.00–1.00) 0.76 1.00 (1.00–1.00) 0.76 1.00 (1.00–1.00) 0.76
hs-CRP (per 1-mg/dL increase) 1.00 (0.93–1.08) 0.96 1.00 (0.93–1.08) 0.96 1.00 (0.93–1.08) 0.96
ty C
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However, most of those studies included PEW assessed by the
SGA only once at a certain time in the analysis. Similar to the
current study, however, some studies have tried to elucidate the
impact of the changes in SGA ratings on clinical outcomes.
Braunschweig et al22 and Allard et al23 found that the decline in
nutritional status determined by SGA in hospitalized patients
for more than 7 days was a significant independent predictor of
a longer length of hospital stay and higher complication rates
regardless of the patient’s nutritional status on admission. In
ESRD patients, the NECOSAD-II study also found that mal-
nutrition at baseline (SGA score 1–5) was significantly associ-
CI¼ confidence interval, HR¼ hazard ratio, hs-CRP¼ high-sensitiviated with 7-year mortality and that time dependently, this
association was even stronger.14 In agreement with the afore-
mentioned studies, the present study showed that the change in
FIGURE 4. Kaplan–Meier plot for all-cause mortality of the reclas-
sified patients group according to the trend of nutritional status
change (3 categories). Numbers in the box areP values of pairwise
comparisons between 2 groups. WN group: SGA A group, MN
group: SGA B or C group. MN¼malnourished, SGA¼ subjective
global assessment, WN¼well nourished.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.nutritional status assessed by SGA at baseline and 12 months
after dialysis commencement was significantly associated with
all-cause mortality, whereas nutritional status assessed by SGA
at the time of dialysis initiation was not an independent pre-
dictor of the clinical outcome in Korean incident dialysis
patients. These findings further underscore the importance of
regular monitoring of nutritional status rather than nutritional
assessment at a single time, because nutritional status can
change in ESRD patients after commencing dialysis treatment.
However, in the subgroup of patients who died within 1 year, the
risks of all-cause mortality between baseline WN and MN
groups were not statistically different (Supplementary Figure
3, http://links.lww.com/MD/A698). These findings may
suggest that other factors such as cardiovascular diseases rather
than malnutrition are more closely associated with mortality
within 1 year of dialysis commencement.
Although many studies showed that nutrition-related vari-
ables, such as BMI, lean bodymass, anthropometric parameters,
and serum creatinine, albumin, prealbumin, transferrin, ferritin,
and CRP concentrations,24–27 were significantly correlated with
SGA scores, some investigators failed to demonstrate these
relations.28,29 A previous study by Jones et al24 found signifi-
cant differences in midarm circumference, midarm muscle
circumference, and serum creatinine and CRP concentrations,
but not serum albumin concentrations, between patients classi-
fied as SGA A (WN) and B (mildly to moderately MN). In
addition, they showed that the composite nutrition score was
associated with the 3-point SGA score, 7-point SGA score,
BMI, midarm circumference, and triceps skinfold, except for
serum albumin concentrations. In contrast, serum albumin
-reactive protein, MN¼malnourished, WN¼well nourished.concentrations were significantly correlated with CRP concen-
trations, suggesting that serum albumin concentrations were
related to inflammation rather than nutrition state in patients
www.md-journal.com | 7
nutritional status in WN patients and intervening to improveundergoing HD. Our study revealed that BMI was significantly
increased in group 2 at 12 months compared with that at
baseline, and serum albumin concentrations were significantly
increased after 12 months of dialysis in all 4 groups; however,
there were no significant differences in the changes in BMI and
serum albumin concentrations among the 4 groups. Moreover,
although the nutritional status was worsened in group 3, serum
creatinine concentrations were significantly increased in this
group, whereas serum creatinine concentrations were not chan-
ged in group 2, in which the nutritional status was improved.
Furthermore, the change in nutritional status assessed by SGA,
rather than the changes in BMI and serum albumin and crea-
tinine concentrations, was demonstrated to be a significant risk
factor for all-cause mortality (Supplementary Table 4, http://
links.lww.com/MD/A698). These findings suggest that the
change in nutritional status determined by SGA may be more
closely associated with clinical outcomes than the changes in
other nutritional parameters in incident ESRD patients.
Meanwhile, we reclassified the patients into 3 groups
according to the changes in 3-category and 7-point scale
SGA during the follow-up period as stationary, improving,
and worsening and compared the mortality risks among these
groups. The worsening groups by 3-category and 7-point scale
were revealed to be associated with higher mortality risks, but a
statistical significance was found only in nutritional status
changes stratified by 3 categories but not by 7-point scale.
The main difference between the 2 classifications was whether
patients with a 1-point SGA score change (for instance, 3 to 4 or
7 to 6) was considered as stationary by 3 categories or changed
(improving or worsening, respectively, by 7-point scale).
Supplementary Figure 4, http://links.lww.com/MD/A698 is
the Kaplan–Meier plot according to the baseline SGA score
using 7-point scale, revealing that the mortality risk of the SGA
7 group was similar to the SGA 6 group, but was significantly
lower compared with the SGA 3 and 5 groups. Based on these
findings, we surmised that 7-point scale could subdivide their
nutritional status, but the effect of SGA score changes upon 7-
point scale was not powerful to predict all-cause mortality
because of a relatively large number of patients with a 1-point
SGA score change within the same 3-category SGA subgroup.
The most common cause of death in the current study was
cardiovascular disease, followed by infection (Supplementary
Table 5, http://links.lww.com/MD/A698). In ESRD patients, it
is well known that malnutrition, inflammation, and atheroscle-
rosis are connected (and termed MIA syndrome), implying that
malnutrition may lead to increased cardiovascular mortality in
these patients.1 In addition, malnutrition is associated with a
defective immune system, resulting in susceptibility to infec-
tious disease.30 In the present study, compared with groups 1
and 3, group 2 had significantly higher baseline concentrations
of hs-CRP; however, they significantly decreased after 12
months. In contrast, significantly lower hs-CRP concentrations
at baseline in group 3 compared with those in group 2 were only
slightly increased at 12 months after dialysis initiation. These
differential changes in hs-CRP concentrations may account for
the opposite clinical outcomes between groups 2 and 3.
This study has several limitations. First, as the study
subjects were all Korean incident dialysis patients, the associ-
ation between the changes in nutritional status determined using
the SGA and all-cause mortality may not be generalized to other
populations. Second, although the SGA scores were determined
Kwon et alby trained investigators at each study center, they were not
validated by a third person. In addition, SGA scores were
determined in 901 patients (98.6%) at baseline and after 12
8 | www.md-journal.commonths by the same investigators. Third, we assessed nutritional
status using the SGA only twice. There is little evidence to guide
the frequency of nutritional state screening for dialysis patients;
however, 4- to 6-monthly monitoring for nutritional status is
suggested in stable ESRD patients undergoing dialysis. Further
studies on sequential SGA scores will be needed to firmly verify
our current results. Fourth, the proportion of the severely MN
patients (0.7% at baseline) was much lower than the previous
studies; therefore, severely MN patients could not be analyzed
separately.14,19 This may be attributed to several factors, such as
ethnic differences,31 some degree of residual renal function,32,33
and a relatively long duration of predialysis care by nephrol-
ogists (mean 3.6 years). Fifth, anthropometric indices were not
included, and thus the predictability of the changes in these
indices for mortality was not clarified. Lastly, the number of
patients who died in the present study was relatively small
compared with those in previous studies on Western ESRD
patients. We hypothesize that the difference is mainly attributed
to disparate ethnicities, as the mortality rates of our patients
were comparable with those of Japanese patients undergoing
HD. Despite these limitations, this study highlighted the sig-
nificance of the changes in nutritional status assessed by SGA in
a large prospective ESRD patient cohort with a relatively long
follow-up.
In summary, the changes in nutritional status assessed by
SGA during the first year of dialysis were associated with all-
cause mortality in incident ESRD patients. The mortality rates
in patients whose nutritional status was poor at the time of
dialysis commencement but improved after 12 months were
comparable with those in patients who had good nutritional
status at both times, whereas WN patients at baseline whose
nutritional status was worse after 12 months of dialysis showed
poor patient survival. These findings suggest that maintaining
Medicine  Volume 95, Number 7, February 2016nutritional status in MN patients at the start of dialysis may
improve clinical outcomes in incident dialysis patients.
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